Literature DB >> 4692683

Central-core disease and malignant hyperpyrexia.

D G Harriman, F R Ellis.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4692683      PMCID： PMC1588736          DOI： 10.1136/bmj.1.5852.545-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Histopathological and neuropharmacological aspects of malignant hyperpyrexia.

Authors:  F R Ellis; N P Keaney; D G Harriman
Journal:  Proc R Soc Med       Date:  1973-01

2.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

3.  Procaine in malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1972-12-02
  3 in total
  1 in total

1.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.